World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: CTRI
Last refreshed on: 24 November 2021
Main ID:  CTRI/2014/10/005094
Date of registration: 13-10-2014
Prospective Registration: No
Primary sponsor: PGIMER
Public title: To find out the rise in hemoglobin and to study the effect of various factors on rise in hemoglobin after blood transfusion in newborn
Scientific title: Determinants of Efficacy of Packed Red Blood Cells Transfusion in Neonates
Date of first enrolment: 01-07-2012
Target sample size: 110
Recruitment status: Completed
URL:  http://www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=8120
Study type:  Observational
Study design:  Other
Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable
 
Phase:  N/A
Countries of recruitment
India
Contacts
Name: Dr Sourabh Dutta   
Address:  Newborn Unit Department of Pediatrics PGIMER Sector 12 Chandigarh 160012 India 160012 Chandigarh, CHANDIGARH India
Telephone:
Email: drpkumarpgi@gmail.com
Affiliation:  Advanced Pediatric Centre PGIMER
Name: Dr Praveen kumar   
Address:  Newborn Unit Department of Pediatrics PGIMER Sector 12 Chandigarh 160012 India 160012 Chandigarh, CHANDIGARH India
Telephone:
Email: drpkumarpgi@gmail.com
Affiliation:  Advanced Pediatric Centre PGIMER
Key inclusion & exclusion criteria
Inclusion criteria: Neonates (term up to 28 days of age and preterm up to corrected age of four weeks) admitted in Newborn unit requiring PRBC transfusion for anemia
Exclusion criteria: • Life threatening congenital malformations

• Neonates with immune hemolytic condition (defined as a positive Direct Coombâ??s test, exaggerated reticulocyte response or peripheral smear showing evidence of hemolysis)

• Previous â??out of studyâ?? blood transfusions (neonates who have already received PRBC transfusion before being screened for the study) would be excluded. However neonates who have received blood transfusion previously as a part of study and require PRBC transfusion again would be eligible for inclusion.

• Parents not willing to participate in the study and hence refused consent.



Age minimum:
Age maximum:
Gender:
Health Condition(s) or Problem(s) studied
Health Condition 1: null- neonates requiring PRBC transfusion
Intervention(s)
Primary Outcome(s)
â?¢Percent rise in hematocrit at 15 minutes after PRBC transfusion.Timepoint: 15 min
Secondary Outcome(s)
â?¢ Percent rise in hematocrit at 6 hours after PRBC transfusion.

â?¢ Factor affecting the rise of hematocrit

â?¢ Percent rise in hematocrit at15 min, 6 hours and 24 hours of G6PD deficient PRBC transfusion

â?¢ To study the evidence for hemolysis i.e, peripheral blood smear, reticulocyte count, plasma hemoglobin and rise in total serum bilirubin after 24 hours with G6PD deficient PRBC transfusion.

Timepoint: 6 hour and 24 hours
Secondary ID(s)
NIL
Source(s) of Monetary Support
post graduate institute of medical education and research,chandigarh
Secondary Sponsor(s)
Ethics review
Status: Approved
Approval date: 31/12/2012
Contact:
Ethics committee PGIMER
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history